Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China

Background. Acute lung injury (ALI) is a rare but life-threatening pulmonary complication of transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). The aim of this study was to characterize the common risk factors, clinical features, imaging findings, treatments, and out...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang-jie Fang, Lu-yan Chen, Jun-hui Sun, Jian-ying Zhou
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2019/4307651
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560205555040256
author Liang-jie Fang
Lu-yan Chen
Jun-hui Sun
Jian-ying Zhou
author_facet Liang-jie Fang
Lu-yan Chen
Jun-hui Sun
Jian-ying Zhou
author_sort Liang-jie Fang
collection DOAJ
description Background. Acute lung injury (ALI) is a rare but life-threatening pulmonary complication of transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). The aim of this study was to characterize the common risk factors, clinical features, imaging findings, treatments, and outcomes of acute lung injury caused by TACE. Methods. A retrospective study was performed on all TACE-associated ALI cases that were diagnosed at authors’ hospital from January 2015 to June 2018. Results. The study included 14 ALI cases where the mean age of patients was 60.9±11.7 years (range 41-82 years), with a mean onset time of 2.4±1.6 d after TACE. Of the 14 patients, 8 patients (57.1%) developed acute respiratory distress syndrome (ARDS). 7 patients (50%) had underlying chronic respiratory disease and hepatic arteriovenous fistula was detected in 6 patients (42.6%), both of which were significantly higher than control group (P<0.05). Dyspnea (92.9%) was the most common symptoms. Pleural effusion (64.3%), diffuse pulmonary infiltration (42.9%), and accumulation of Lipiodol in lung field (42.9%) were frequent radiologic abnormalities. 11 patients (78.6%) achieved remission after treatment, and the 30-day mortality rate was approximately 21.4%. Patient’s median survival time after the development of ALI was merely 4.3 months, which was obviously worse than control group (4.3 months vs. 13.5 months, P<0.05). Conclusion. This study illustrates that TACE-associated ALI is a rare pulmonary complication with a high mortality rate. We infer that pulmonary Lipiodol embolization might be one of the main causes of TACE-associated ALI. Thus, HCC patients who are at high risk should be closely evaluated and monitored during TACE to avoid such potentially fatal complication.
format Article
id doaj-art-bac9d83c86d141b7bb3303871043ba6e
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-bac9d83c86d141b7bb3303871043ba6e2025-02-03T01:28:10ZengWileyAnalytical Cellular Pathology2210-71772210-71852019-01-01201910.1155/2019/43076514307651Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in ChinaLiang-jie Fang0Lu-yan Chen1Jun-hui Sun2Jian-ying Zhou3Department of Respiratory Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, ChinaDepartment of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, ChinaDepartment of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, ChinaDepartment of Respiratory Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, ChinaBackground. Acute lung injury (ALI) is a rare but life-threatening pulmonary complication of transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). The aim of this study was to characterize the common risk factors, clinical features, imaging findings, treatments, and outcomes of acute lung injury caused by TACE. Methods. A retrospective study was performed on all TACE-associated ALI cases that were diagnosed at authors’ hospital from January 2015 to June 2018. Results. The study included 14 ALI cases where the mean age of patients was 60.9±11.7 years (range 41-82 years), with a mean onset time of 2.4±1.6 d after TACE. Of the 14 patients, 8 patients (57.1%) developed acute respiratory distress syndrome (ARDS). 7 patients (50%) had underlying chronic respiratory disease and hepatic arteriovenous fistula was detected in 6 patients (42.6%), both of which were significantly higher than control group (P<0.05). Dyspnea (92.9%) was the most common symptoms. Pleural effusion (64.3%), diffuse pulmonary infiltration (42.9%), and accumulation of Lipiodol in lung field (42.9%) were frequent radiologic abnormalities. 11 patients (78.6%) achieved remission after treatment, and the 30-day mortality rate was approximately 21.4%. Patient’s median survival time after the development of ALI was merely 4.3 months, which was obviously worse than control group (4.3 months vs. 13.5 months, P<0.05). Conclusion. This study illustrates that TACE-associated ALI is a rare pulmonary complication with a high mortality rate. We infer that pulmonary Lipiodol embolization might be one of the main causes of TACE-associated ALI. Thus, HCC patients who are at high risk should be closely evaluated and monitored during TACE to avoid such potentially fatal complication.http://dx.doi.org/10.1155/2019/4307651
spellingShingle Liang-jie Fang
Lu-yan Chen
Jun-hui Sun
Jian-ying Zhou
Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China
Analytical Cellular Pathology
title Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China
title_full Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China
title_fullStr Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China
title_full_unstemmed Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China
title_short Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China
title_sort clinical characteristics and outcomes of acute lung injury caused by transcatheter arterial chemoembolization for hepatocellular carcinoma a retrospective cohort study from a single institution in china
url http://dx.doi.org/10.1155/2019/4307651
work_keys_str_mv AT liangjiefang clinicalcharacteristicsandoutcomesofacutelunginjurycausedbytranscatheterarterialchemoembolizationforhepatocellularcarcinomaaretrospectivecohortstudyfromasingleinstitutioninchina
AT luyanchen clinicalcharacteristicsandoutcomesofacutelunginjurycausedbytranscatheterarterialchemoembolizationforhepatocellularcarcinomaaretrospectivecohortstudyfromasingleinstitutioninchina
AT junhuisun clinicalcharacteristicsandoutcomesofacutelunginjurycausedbytranscatheterarterialchemoembolizationforhepatocellularcarcinomaaretrospectivecohortstudyfromasingleinstitutioninchina
AT jianyingzhou clinicalcharacteristicsandoutcomesofacutelunginjurycausedbytranscatheterarterialchemoembolizationforhepatocellularcarcinomaaretrospectivecohortstudyfromasingleinstitutioninchina